Literature DB >> 7769716

Human cytomegalovirus proteinase: candidate glutamic acid identified as third member of putative active-site triad.

G A Cox1, M Wakulchik, L M Sassmannshausen, W Gibson, E C Villarreal.   

Abstract

The human cytomegalovirus (HCMV) proteinase is synthesized as a 709-amino-acid precursor that undergoes at least three autoproteolytic cleavages. The mature proteinase, called assemblin, is one of the products of autoproteolysis and is composed of the first 256 amino acids of the precursor. HCMV assemblin and its homologs in other herpes group viruses contain five highly conserved domains (CD1 through CD5). An absolutely conserved serine in CD3 has been shown by site-directed mutagenesis of the simian cytomegalovirus (SCMV) and herpes simplex virus type 1 (HSV-1) enzymes and by inhibitor affinity labeling of the HSV-1 and HCMV enzymes to be the active-site nucleophile of assemblin. An absolutely conserved histidine in CD2 has also been demonstrated by site-directed mutagenesis of the SCMV and HSV-1 enzymes to be essential for proteolytic activity and has been proposed to be a second member of the catalytic triad of this serine proteinase. We report here the use of site-directed mutagenesis to investigate the active-site amino acids of HCMV assemblin. Substitutions were made for the CD3 serine and CD2 histidine residues implicated as active-site components, and for other amino acids whose influence on enzyme activity was of interest. The mutant proteinases were tested in a transient transfection assay for their ability to cleave their natural substrate, the assembly protein precursor. Results of these experiments verified that HCMV CD3 serine (Ser-132) and CD2 histidine (His-63) are essential for proteolytic activity and identified a glutamic acid (Glu-122) within CD3 that is also essential for proteolytic activity and may be conserved among all herpesvirus assemblin homologs. We suggest that CD3 Glu-122, CD3 Ser-132, and CD2 His-63 constitute the active-site triad of this serine proteinase.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7769716      PMCID: PMC189198          DOI: 10.1128/JVI.69.7.4524-4528.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

Review 1.  Analytical luminescence: its potential in the clinical laboratory.

Authors:  T P Whitehead; L J Kricka; T J Carter; G H Thorpe
Journal:  Clin Chem       Date:  1979-09       Impact factor: 8.327

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

Review 3.  Serine proteases: structure and mechanism of catalysis.

Authors:  J Kraut
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The protease of herpes simplex virus type 1 is essential for functional capsid formation and viral growth.

Authors:  M Gao; L Matusick-Kumar; W Hurlburt; S F DiTusa; W W Newcomb; J C Brown; P J McCann; I Deckman; R J Colonno
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

6.  Purification and kinetic characterization of human cytomegalovirus assemblin.

Authors:  M C Smith; J Giordano; J A Cook; M Wakulchik; E C Villarreal; G W Becker; K Bemis; J Labus; J S Manetta
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

Review 7.  Evolution of proteolytic enzymes.

Authors:  H Neurath
Journal:  Science       Date:  1984-04-27       Impact factor: 47.728

8.  Identification and characterization of a herpes simplex virus gene product required for encapsidation of virus DNA.

Authors:  V G Preston; J A Coates; F J Rixon
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

9.  Herpesviridae. Definition, provisional nomenclature, and taxonomy. The Herpesvirus Study Group, the International Committee on Taxonomy of Viruses.

Authors:  B Roizman; L E Carmichael; F Deinhardt; G de-The; A J Nahmias; W Plowright; F Rapp; P Sheldrick; M Takahashi; K Wolf
Journal:  Intervirology       Date:  1981       Impact factor: 1.763

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  8 in total

1.  Enzymatic activities of human cytomegalovirus maturational protease assemblin and its precursor (pPR, pUL80a) are comparable: [corrected] maximal activity of pPR requires self-interaction through its scaffolding domain.

Authors:  Edward J Brignole; Wade Gibson
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

2.  Cytomegalovirus assemblin: the amino and carboxyl domains of the proteinase form active enzyme when separately cloned and coexpressed in eukaryotic cells.

Authors:  M R Hall; W Gibson
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

3.  Independently cloned halves of cytomegalovirus assemblin, An and Ac, can restore proteolytic activity to assemblin mutants by intermolecular complementation.

Authors:  M R Hall; W Gibson
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

4.  Active residues and viral substrate cleavage sites of the protease of the birnavirus infectious pancreatic necrosis virus.

Authors:  S Petit; N Lejal; J C Huet; B Delmas
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

5.  Characterization of a soluble stable human cytomegalovirus protease and inhibition by M-site peptide mimics.

Authors:  R L LaFemina; K Bakshi; W J Long; B Pramanik; C A Veloski; B S Wolanski; A I Marcy; D J Hazuda
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

6.  Initial characterization of autoprocessing and active-center mutants of CMV proteinase.

Authors:  S W Snyder; R P Edalji; F G Lindh; K A Walter; L Solomon; S Pratt; K Steffy; T F Holzman
Journal:  J Protein Chem       Date:  1996-11

7.  The protease and the assembly protein of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8).

Authors:  A Unal; T R Pray; M Lagunoff; M W Pennington; D Ganem; C S Craik
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

8.  Inhibiting a dynamic viral protease by targeting a non-catalytic cysteine.

Authors:  Kaitlin R Hulce; Priyadarshini Jaishankar; Gregory M Lee; Markus-Frederik Bohn; Emily J Connelly; Kristin Wucherer; Chayanid Ongpipattanakul; Regan F Volk; Shih-Wei Chuo; Michelle R Arkin; Adam R Renslo; Charles S Craik
Journal:  Cell Chem Biol       Date:  2022-03-31       Impact factor: 9.039

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.